Neurodevelopmental outcome of children treated with antenatal thyrotropin-releasing hormone

Pediatrics

Volumn 110, Issue 2 I, 2002, Pages 249-253

  Briët, Judy M ^a,b   Van Sonderen, Loekie ^a   Buimer, Maarten ^a   Boer, Kees ^a   Kok, Joke H ^a  

^a Departments of Neonatology   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Developmental outcome outcome studies; Follow up; Thyrotropin releasing hormone

Indexed keywords

CORTICOSTEROID; PLACEBO; PROTIRELIN;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CHILD; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEVELOPMENT; META ANALYSIS; MULTICENTER STUDY; NERVOUS SYSTEM DEVELOPMENT; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE;

CHILD DEVELOPMENT; CLINICAL TRIALS; DELIVERY, OBSTETRIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; NEUROLOGIC EXAMINATION; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PSYCHOMOTOR PERFORMANCE; THYROTROPIN-RELEASING HORMONE;

EID: 0036331629     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.110.2.249     Document Type: Article

References (29)

1. Collaborative trial of prenatal thyrotropin-releasing hormone and corticosteroids for prevention of respiratory distress syndrome
2. Australian collaborative trial of antenatal thyrotropin-releasing hormone (ACTOBAT) for prevention of neonatal respiratory disease
3. Thyrotropin-releasing hormone for prevention of neonatal respiratory disease
4. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants
5. A randomized, controlled trial of antepartum thyrotropin-releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants
6. Fetal lung maturation: The combined use of corticosteroids and thyrotropin-releasing hormone
7. Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences
8. Controlled trial of prenatal betamethasone (B) plus TRH for prevention of respiratory distress syndrome (RDS) in preterm infants
9. Pharmacologic pulmonary maturation in preterm premature rupture of membranes
10. Maternal administration of thyrotropin-releasing hormone for prevention of neonatal respiratory distress syndrome
11. Two trials of antenatal thyrotrophin-releasing hormone for fetal maturation: Stopping before the due date
12. A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight
13. Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors
14. Plasma thyroid hormones and prolactin in premature infants and their mothers after prenatal treatment with thyrotropin-releasing hormone
15. Effect of maternal administration of thyrotropin releasing hormone on the preterm fetal pituitary-thyroid axis
16. Thyroid hormones and nervous system development
17. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants
18. Delayed cerebral development in twins with congenital hyperthyroidism
19. Prenatal thyrotropin-releasing hormone for preterm birth
20. Australian collaborative trial of antenatal thyrotropin-releasing hormone: Adverse effects at 12-month follow-up
21. The credibility of the ACTOBAT follow-up study
22. Neurological development in infancy
23. School performance at nine years of age in very premature and very low birth weight infants: Perinatal risk factors and predictors at five years of age
24. Predicting preschool behavior problems from temperament and other variables in infancy
25. Plasma thyroid hormones in premature infants: Effect of gestational age and antenatal thyrotropin-releasing hormone treatment
26. Neurodevelopmental outcome of preterm infants with an abnormal thyrotropin-releasing hormone (TRH) stimulation test at 28 days of life
27. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age
28. Thyroid function 6 years after prenatal treatment with thyrotropin-releasing hormone